ADM Archer-Daniels-Midland Co

Archer-Daniels-Midland processes and distributes agricultural commodities, producing ingredients for food, beverages, animal feed, and industrial applications. Sector: Consumer Staples.

Archer-Daniels-Midland Co (ADM) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 3.33%, WACC is 7.14%, and the economic spread is -3.81%. On balance, the spread between returns and funding costs is negative — a dynamic that pressures intrinsic value unless operating performance improves. Supporting metrics show ROE at 4.76% and ROA at 1.88%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that likely needs operating improvement before returns quality can be considered durable.

Assessed on a multiple basis, trailing P/E of 33.20, forward P/E of 17.76, PEG of 7.21. The difference between trailing and forward multiples is significant, suggesting investors are paying today for earnings that have not yet been fully delivered. At this PEG level, the valuation case rests more on quality, scarcity, or market leadership than on earnings growth alone. The company carries an aggregate current ratio of 1.37, pointing to constrained near-term balance sheet coverage. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

The margin stack reads as follows: gross margin sits at 6.27%, operating margin at 1.78%, and free cash flow margin at 5.24%. Thin gross margins leave limited room for operational leverage — cost discipline at every layer becomes critical. Operating margins this compressed indicate businesses where the path to earnings remains dependent on future scale. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

The forward view combines two signals: the estimated 12-month price change of -14.11%, where analyst assumptions imply downside unless operating trends re-accelerate, while TTM revenue growth of -6.15% pointing to declining revenues that, if sustained, could pressure margins and forward estimates. The projected 12-month EPS growth rate of 87.0% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The quantitative review surfaces concerns across multiple dimensions — investors considering a position here should be aware of the risks and size exposures accordingly.

This summary is based on publicly available quantitative data and is not intended as investment advice. Carefully consider your personal financial circumstances before making any decisions.